Take Control Of Your Conference Calls

MURRAY, Utah--(BUSINESS WIRE)--Nov. 27, 2001--Wasatch Ph= armaceutical Inc. (OTCBB:WSCH - news)= CEO Gary Heesch announced today a marketing campaign directed to physicia= ns. A direct link has been established on a physician recruiting Web site = making available therapies for the treatment of cystic acne, acne, follicu= litis and skin rejuvenation. Physicians will find the benefits of these tr= eatment therapies by logging on to the "X Acne" link at the P= hysician Search website. This physician search Web site typically rece= ives over 200,000 hits per month. Mr. Heesch reminded, "Our tr= eatment therapy products are also available via the AISC Online Store.&quo= t;

These skin treatmen= t products come in kit form providing a 90-day supply to patients for the = full treatment program. Included in the kit is an instructional video on t= he treatment therapy allowing the patient to use these products in their h= ome. The therapies, when used as instructed, achieve a success rate of = eradication in excess of 90% with no side effects of any consequence. = Previously, these therapies and associated products were only available th= rough the two prototype clinics in Utah. The availability of these product= s will open the way for family practitioners, pediatricians, internists an= d other primary care physicians to retain their patients under their care = during the treatment of these common skin disorders. The benefit to ins= urance providers is the potential to save millions of dollars in reimburse= ment costs by freeing the physician and the patient from ongoing treatment= .

In the coming year, s= ix additional therapies will be made available for a broad range of sk= in disorders that are badly in need of successful therapies.

= Gary Heesch also announced the listing of W= asatch Pharmaceutical stock on the Frankfurt and Berlin Exchanges in Ge= rmany. Active trading on these exchanges will take place upon the comp= letion of a research report in Germany. Said Mr. Heesch, "We feel thi= s is a significant event as Wasatch will gain wider exposure as a l= eader in dermatology and will put buying pressure on its stock t= o reflect the true value of a company that has committed years = of research and development of products that allow people with serious ski= n disorders to live normal and more productive lives."

<= font face=3DArial size=3D1>There may be forward-looking statements in t= his release. Investors are cautioned that such forward-looking statements = involve risks and uncertainties, including, without limitation, continued = acceptance of the Company's products, increased levels of competition, new= products introduced by competitors, changes in the rates of subscriber ac= quisition and retention, and other risks detailed from time to time in the= Company's periodic reports filed with the Securities and Exchange Commiss= ion.

=C0=CF =C1=A4

=BF=AC=BC=F6=20 =B3=BB=BF=EB

=C2=FC =B0=ED

=A1=A12002. 2. 28
=A1=A1=A1=A1~2002. 8. 29

= - =C1=DF=B1=B9=BE=EE =B1=E2=C3=CA~=C1=DF=B1=DE=B0=FA=C1=A4=20
- =BD=C7=BF=EB =C7=A5=C1=D8=C1=DF=B1=B9=BE=EE, =C8= =B8=C8=AD, =B9=AE=B9=FD, =C0=DB=B9=AE
- HSK=BD=C3=C7=E8(=F1=E9=CF=D0=F9=D3=E5=DE=E2=A9=F8=C1=CD=C5=E3=CB)

1=C0=CF 4=BD=C3=B0= =A3 (=BF=C0=C0=FC)

=A1=A12002. 2. 28
=A1=A1=A1=A1~2002. 5. 30

- =C1=DF=B1=B9=C7= =D0 =B0=AD=C0=C7
=A1=A1(=BF=AA=BB=E7, =C1=F6=B8=AE, =B0=E6=C1=A6, = =B9=AE=C8=AD, =B9=FD=B7=FC, =B1=B3=C0=B0=B5=EE)
- =BD=C9=BE=E7=B4=EB=C7=D0=B1=B3 =C3=DF=C3=B5 =B4= =EB=C7=D0=BB=FD=B0=FA Free Talking

1=C0=CF 2=BD=C3=B0= =A3 (=BF=C0=C8=C4)

=A1=A12002. 5. 31
=A1=A1=A1=A1~2002. 8. 30

- =C4=C4=C7=BB=C5= =CD =B1=E2=C3=CA=B1=B3=C0=B0 (=C1=DF=B1=B9 =C4=C4=C7=BB=C5=CD =C8=AF=B0=E6= =BC=F7=C1=F6)
- JAVA Programming (SCJP=B0=FA=C1=A4)

1=C0=CF 2=BD=C3=B0= =A3 (=BF=C0=C8=C4)

=A1=A12002. 7

- =C1=DF=B1=B9=B9= =AE=C8=AD =C0=AF=C0=FB=C1=F6 =C5=BD=B9=E6 (4=B9=DA5=C0=CF)

=B9=E8=B3=B6=BF=A9= =C7=E0
(=B1=B3=C5=EB, =BC=F7=BD=C4=C1=A6=B0=F8)

2002=B3=E2 2=BF= =F9 20=C0=CF =C1=A2=BC=F6=B8=B6=B0=A8 (=BF=AC=BC=F6=B1=DD, =C1=D6=B9=CE=B5= =EE=B7=CF=B5=EE=BA=BB 3=C5=EB, =B9=DD=B8=ED=C7=D4=C6=C7 =BB=E7=C1=F85=B8=C5= , =B5=B5=C0=E5) 2002=B3=E2 2=BF=F9 25=C0=CF =BA=F1=C0=DA, =BD=C5=C3=BC=B0=CB=BB=E7 =BF=CF= =B7=E1 2002=B3=E2 2=BF=F9 26=C0=CF =C3=E2=B1=B9 =BF=B9=BA=F1=BC=D2=C1=FD (=B4=E7= =BB=E7 =C8=B8=C0=C7=BD=C7=BF=A1=BC=AD =BF=A9=B1=C7/=BA=F1=C0=DA =B5=E5=B8= =B2) 2002=B3=E2 2=BF=F9 28=C0=CF 12:30 =C0=CE=C3=B5=B1=B9=C1=A6=B0=F8=C7=D7=BF= =A1=BC=AD =C1=DF=B1=B9 =BD=C9=BE=E7=C0=B8=B7=CE =C3=E2=B1=B9 (=C1=DF=B1=B9= =BA=CF=B9=E6=C7=D7=B0=F8) 14:30 =BD=C9=BE=E7=B4=EB=C7=D0=B1=B3 =B1=E2=BC=F7=BB=E7 =C0= =D4=BC=D2 =B9=D7 =BF=C0=B8=AE=BF=A3=C5=D7=C0=CC=BC=C7 2002=B3=E2 7=BF=F9 =C1=DF=B1=B9=B9=AE=C8=AD =C0=AF=C0=FB=C1=F6 =C5=BD=B9=E6= (4=B9=DA5=C0=CF) 2002=B3=E2 8=BF=F9 HSK =BD=C3=C7=E8(=F1=E9=CF=D0=F9=D3=E5=DE=E2=A9=F8=C1=CD= =C5=E3=CB) =C0=C0=BD=C3 2002=B3=E2 8=BF=F928=C0=CF =C1=BE=B0=AD =B9=D7 =BC=F6=B7=E1=BD=C4 2002=B3=E2 8=BF=F929=C0=CF =C1=DF=B1=B9 =BD=C9=BE=E7=BF=A1=BC=AD =C0=CE=C3= =B5=B1=B9=C1=A6=B0=F8=C7=D7=C0=B8=B7=CE =B1=CD=B1=B9

REASONS TO BUY PLLX<= /font>

= 1.

PLLX projects that if th= e company captures 1/5 of 1% of the recorded music market the company will= generate at least $55 million in cumulative revenues over the next 5 year= s. The company currently operates with an extremely low overhead of only $= 350,000 - $500,000 per year.

PLLX currently manages two up= -and-coming bands, Track 10 and TEK3. Harder Beat magazine has given= Tek 3 rave reviews and has already labeled them a band with =FFFFFF93the = potential of having a long career.=FFFFFF94

PLLX has recen= tly entered into a consulting agreement with David H. Chidekel, a leading = New York entertainment attorney whose client list has included such big na= mes as Universal Records Group, EMI Records, Arista Records, and Shaggy, F= ilter and Dee Lyte. Mr. Chidekel joins Parallax=FFFFFF92s advisory b= oard and will serve as a consultant during the company=FFFFFF92s expansion= .

PLLX has joined forces with Uncommon Media Group (OTCB= B:UMDA) to promote Tek 3 on an enhanced CD-ROM in over 350,000 issues of t= he June edition of the World Wrestling Federation=FFFFFF92s RAW Maga= zine. Parallax also plans on circulating over 800,000 copies of a CD= -ROM featuring Track 10 and Tek 3 in the July issue of SPIN magazine as we= ll.

PLLX test marketed two songs= by artist Track 10 on radio station KQKY Hits 106FM. Both consecutive tes= ts resulted in the songs becoming the number one request topping major lab= el artists including Alien Ant Farm, Gorillaz, N*SYNC, Michael Jackson, St= aind, Alicia Keys and Destiny=FFFFFF92s Child. =

PLLX recording artist Tek 3 is currently collaborating with p= roducer Carlos Broady for tracks on their debut release on Parallax Record= s. Mr. Broady has produced tracks for such well known artists as Sean Puff= y Combs =FFFFFF91Puff Daddy=FFFFFF92 (Bad Boy/Arista), Notorious B.I.G. (B= ad Boy/Arista), Mase (Bad Boy/Arista), Lil=FFFFFF92 Kim (Untentertainment/= Arista) and LL Cool J (Def Jam Music Group). Recently, Broady produced tra= cks for artist India Arie whose debut album on Universal Records was nomin= ated for seven (7) Grammy Awards including Album of the year. &nbs= p;

&n= bsp; &nbs= p; =

CONCLUS= ION

Parallax Entertainment, Incorporated has brilliantl= y positioned itself to become a leader in the online music industry. = Not only does it represent and license hot new bands, but it also serves = as an online portal for all types of musicians seeking to expand their aud= iences. Overhead costs are kept at a minimum and revenue potential i= n the industry is enormous. Management is actively consulting entert= ainment industry experts like David Chidekel who has represented numerous = major label artists and who is currently =FFFFFF93of counsel=FFFFFF94 to t= he prestigious law firm that also represents NSYNC and LFO. All in a= ll, if looking for a play in the exploding online music market then PLLX i= s definitely worth a second look

<= /td>

<= img height=3D2 src=3Dhttp://www.businessworldwide.net/sik/spacer.gif width= =3D280 NOSEND=3D1>

<= td width=3D96 height=3D27> = $0.08

&nbs= p; SYMBOL:	&n= bsp; PLLX
CURRENT PRICE:
&= nbsp;52 WEEK HIGH:	$0.16
&n= bsp; 52 WEEK LOW:	$= 0.05

COMPANY BACKGROUND

Parallax Entertainment, Inc. is a music indus= try concern operating two divisions: Parallax Records and Hitdial.co= m. = Parallax Records produces music for a variety of categories and main= tains ownership of the intellectual property rights of the albums produced= . The company develops the artist and then markets and licenses the finish= ed product to major record labels. Revenue is generated from advance= s on future royalties, royalties, publishing royalties, merchandise sales,= and merchandise royalties. Hi= tDial.com acts as a promotional outlet and e-commerce solution for musicia= ns via the Internet. Musicians can apply to obtain a =FFFFFF93micro-= page=FFFFFF94 on the HitDial site where they can display a biography, audi= o sample, and photo of their band. As members, musicians will benefi= t by gaining a larger fan base and the company profits from the sale of th= e members=FFFFFF92 merchandise and the gathering of valuable consumer data= statistics on the industry.

= INDUSTRY ST= ATS

Over the last decade the music industry has been consolidated i= nto 5 conglomerates controlling 75% of the world=FFFFFF92s music market: S= ony Corp., AOL Time Warner, Inc., EMI Group, Bertelsmann AG, and Vivendi U= niversal. With consumers no longer replacing old cassettes, albums and 8-t= racks, sales of back catalogue music has tapered off. According to SoundSc= an, sales of recorded music dropped by roughly $50 million (US) last year.= With investors to report to, these major labels are responding by restruc= turing. In an effort to deliver short-term profits, these mega-giants are = looking for quick hits and have ceased the age old process of discovering = and developing talent. Now major record labels are turning to independent = labels and artist management companies in search of already developed tale= nt. This has created an expanding and lucrative niche for companies like P= arallax. Examples of two independent labels that have prospered during rec= ent consolidations are Wind-Up Records (Creed, Drowning Pool) and Roadrunn= er Records (Nickelback, Slipknot).

The 2000 global music market w= as worth $36.9 Billion with total unit sales of over 3.5 billion. Wi= th such an enormous potential market, even the smallest gain of market sha= re could mean millions for Parallax Entertainment. Jupiter Media Metr= ix, a leader in e-commerce data development, expects a continual annual gr= owth rate of 76% in online music sales (growing to about $2.6 billion in 2= 003). With many top recording artists actively recruiting agents to = manage their Internet presence, Parallax Entertainment Inc. is perfectly p= ositioned to become an industry leader.

<= b>To be removed from future = mailings, please reply to this email with "Remove" in the subjec= t line.

<= b>
DISCLAIMER:
Information within this email co= ntains "forward looking statements" within the meaning of Sectio= n 27A of the Securities Act of 1933 and Section 21B of the Securities Exch= ange Act of 1934. Any statements that express or involve discussions with = respect to predictions, expectations, beliefs, plans, projections, objecti= ves, goals, assumptions or future events or performance are not statements= of historical fact and may be "forward looking statements."
=
Forward looking statements are based on expectations, estimates and = projections at the time the statements are made that involve a number of&n= bsp;risks and uncertainties which could cause actual results or events to = differ materially from those presently anticipated. Forward looking statem= ents in this action may be identified through the use of words such as &qu= ot;projects", "foresee", "expects", "will,&q= uot; "anticipates," "estimates," "believes,= " "understands" or that by statements indicating certain ac= tions "may," "could," or "might" occur. = ; All information provided within this email pertaining to investing, stoc= ks, securities must be understood as information provided and not investme= nt advice. Emerging Equity Alert advises all readers and subscribers to se= ek advice from a registered professional securities representative be= fore deciding to trade in stocks featured within this email. None of= the material within this report shall be construed as any kind of investm= ent advice.

In compliance with the Securities Act of 1933, Sectio= n17(b), Emerging EquityAlert discloses the receipt of $10,000 cash from a = third party for the publication of this report and additional service= s related to PLLX. Be aware of an inherent conflict of interest resulting = from such compensation. All factual information in this report was ga= thered from public sources, including but not limited to SEC filings, Comp= any Press Releases, and the company's website. Emerging Equity Alert= believes this information to be reliable but can make no guarantee as to = its accuracy or completeness. Use of the material within this email consti= tutes your acceptance of these terms.

To be removed from future mailings, please r= eply to this email with "Remove" in the subject line.=

MURRAY, Utah--(BUSINESS WIRE)--Nov. 27,= 2001--Wasatch Pharmaceutical Inc. (OTCBB:WSCH - news) CEO Gary Heesch announced today a marketing campaign dir= ected to physicians. A direct link has been established on a physician rec= ruiting Web site making available therapies for the treatment of cystic ac= ne, acne, folliculitis and skin rejuvenation. Physicians will find the ben= efits of these treatment therapies by logging on to the "X Acne&qu= ot; link at the Physician Search website. This physician search Web si= te typically receives over 200,000 hits per month. Mr. Heesch remin= ded, "Our treatment therapy products are also available via the AISC = Online Store."

Th= ese skin treatment products come in kit form providing a 90-day supply to = patients for the full treatment program. Included in the kit is an instruc= tional video on the treatment therapy allowing the patient to use these pr= oducts in their home. The therapies, when used as instructed, achieve a success rate of eradication in excess of 90% with no side effects of any = consequence. Previously, these therapies and associated products were = only available through the two prototype clinics in Utah. The availability= of these products will open the way for family practitioners, pediatricia= ns, internists and other primary care physicians to retain their patients = under their care during the treatment of these common skin disorders. T= he benefit to insurance providers is the potential to save millions of dol= lars in reimbursement costs by freeing the physician and the patient from = ongoing treatment.

In the = coming year, six additional therapies will be made available for a = broad range of skin disorders that are badly in need of successful therapi= es.

Gary Heesch also announced= the listing of Wasatch Pharmaceutical stock on the Frankfurt and Berli= n Exchanges in Germany. Active trading on these exchanges will take pl= ace upon the completion of a research report in Germany. Said Mr. Heesch, = "We feel this is a significant event as Wasatch will gain wider ex= posure as a leader in dermatology and will put buying pressu= re on its stock to reflect the true value of a company that has= committed years of research and development of products that allow people= with serious skin disorders to live normal and more productive lives.&quo= t;

There may be forward-lookin= g statements in this release. Investors are cautioned that such forward-lo= oking statements involve risks and uncertainties, including, without limit= ation, continued acceptance of the Company's products, increased levels of= competition, new products introduced by competitors, changes in the rates= of subscriber acquisition and retention, and other risks detailed from ti= me to time in the Company's periodic reports filed with the Securities and= Exchange Commission.

Wasatch Pharmaceutical Inc. Announ= ces a New Physician Marketing Campaign and Listing On German Stock Exchang= es

Wasatch Pharmaceu= tical Inc. Announces a New Physician Marketing Campaign and Listing On Ger= man Stock Exchanges